/Investor DB

Wallonie Entreprendre — Full Portfolio

15 tracked investments · listed companies and verified rows first

Aboleris Pharmaaboleris-pharma.comin✓ verified

AbolerIS Pharma develops therapeutic approaches that regulate the immune system by inducing immune tolerance while preserving useful immune responses, targeting inflammatory, autoimmune, and degenerative diseases.

BiotechHealthtech

Ignacio Anegon(Co-founder, Senior Consultant & SAB Member)inCarole Guillonneau(Co-founder & Head of Research)inFrançois-Xavier Hubert(Co-founder, Past President & Board Member)

Co-investorsCriteria Bio VenturesNewton BiocapitalSound BioventuresSambrinvest

ATB Therapeuticsatbtherapeutics.comin𝕏Nov 2024✓ verified

ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.

BiotechHealthtechMedical Devices

Dr. Mark Throsby(Chief Executive Officer)

Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersEQT Life SciencesSambrinvestEQT

e-pease-peas.comin𝕏✓ verified

e-peas develops energy harvesting power management ICs (ambient energy managers) and low-power microcontrollers that improve the autonomy of intelligent devices for markets including smart home, consumer electronics, and industrial IoT.

EnergyHardwareIoTSemiconductorsLouvain-la-Neuve, BE

Geoffroy Gosset(Founder)inJulien De Vos(Founder)inChristian Ferrier(CMO - Chief Marketing Officer)inCoralie Brancart(CFO - Chief Financial Officer)Abdelali Lotfi(Sr VP Operations and Global Supply)

Co-investorsNivelinvestAirbus VenturesCrédit Mutuel EquityOtium CapitalPartech VenturesVIVES Partners+1 more

Eyedpharmaeyedpharma.comin✓ verified

EyeD Pharma develops pharmaceutical treatments focused on ophthalmology, particularly for glaucoma and related eye conditions.

BiotechHealthtechMedical DevicesLiège, BE

Mélanie Mestdagt(Chief Executive Officer & Co-Founder)inMarc Foidart(Co-Founder)inJean-Marie Rakic(Co-Founder)

Co-investorsFund+

Neuvasqneuvasq.comin✓ verified

Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders.

BiotechDeep TechHealthtechMedical Devices

Benoit Vanhollebeke(Scientific Founder)inDenis Bedoret(Executive Director)in

Co-investorsNewton BiocapitalSambrinvest

THERAtRAMEtheratrame.comin✓ verified

THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments.

AI & Machine LearningBiotechMedical DevicesLiège, BE

Francesca Rapino(CEO)inPierre Close(CSO)in

Co-investorsQbic Fund

18901890.bein

Wallonie Entreprendre is a regional public financing organization offering credit-guarantee solutions that share lending risk with banks to help Walloon businesses and entrepreneurs obtain bank loans.

FintechGovTech

Co-investorsWING by Digital Wallonia

Axithraaxithra.comin𝕏Sep 2023

Axithra, a spin-off from Ghent University's Photonics Research Group and imec, develops an optics- and photonics-based platform for therapeutic drug monitoring that measures and monitors drug concentrations in blood at the point of care.

Deep TechDigital HealthHealthtechMedical Devices

Co-investorsimec.xpandKurma PartnersQbic FundWhite Fund

Cluehelloclue.com𝕏Apr 2026

Clue is a menstrual and reproductive health app that lets people track their periods, cycle, ovulation, fertility, and related symptoms, and contributes anonymized data to scientific research with institutions such as Johns Hopkins and the Gates Foundation.

ConsumerDigital HealthFemTechWellness & FitnessBerlin, DE

Ida Tin(Founder)inHans Raffauf(Founder)Moritz von Buttlar(Founder)Mike LaVigne(Founder)Rhiannon White(CEO)inGreg Ryzhov(CTO)

Co-investorsAtlanticBalderton CapitalExpedite VenturesFJ LabsFuture Positive CapitalGotham Gal Ventures+9 more

Novadip Biosciencesnovadip.comin

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

BiotechDeep TechHealthtechMedical DevicesLouvain, BE

Dr. Denis Dufrane(Founder & Professor)in

BoardEric Paul Pâques(Chairman)

Co-investorsNew Science VenturesÉpimèdeFund+VIVES PartnersSambrinvest

Odooodoo.shNov 2024 · $527M

Odoo.sh is a cloud development and hosting platform for Odoo projects, offering GitHub integration, automated testing, staging and production branches, and managed infrastructure.

Cloud ComputingDeveloper ToolsSaaS

Fabien Pinckaers(Founder)in

Co-investorsAdelieBlackRockCapitalGHarbourVest Partners (Canada)Sequoia CapitalSummit Partners

Skysunskysun.euin

Skysun installs solar photovoltaic panels and battery storage systems on commercial properties—rooftops, parking areas, and land—with no upfront investment from the client.

CleantechEnergyEnterprise Software

Léopold Coppieters(Founder)inArthur Dawans(Founder)in

Co-investorsAndera Partners

Sovossovos.com

Sovos provides a cloud-based platform for global tax compliance, helping companies manage indirect tax, e-invoicing, and regulatory reporting across roughly 200 countries.

Enterprise SoftwareFintechSaaS

Co-investorsTA AssociatesBlackFin Capital PartnersSeeder FundShapers

W.A.L.T.E.Rw-alter.bein𝕏

W.ALTER is a financial partner for social economy and cooperative projects in Wallonia, Belgium, providing financing solutions to entrepreneurs from idea to growth stage.

FintechImpact & Social GoodLiège, BE

Co-investorsWING by Digital Wallonia

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

555 Bryant Street

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.